Literature DB >> 15031802

Time-lapse confocal imaging of development of Bacillus anthracis in macrophages.

Gordon Ruthel1, Wilson J Ribot, Sina Bavari, Timothy A Hoover.   

Abstract

Macrophages attempt to battle infection with Bacillus anthracis spores by phagocytosis of the spores. However, it is believed that B. anthracis spores may survive phagocytosis and may actually use the macrophages that ingest them as a means of transport to lymph nodes. Thus far, the events that occur after spores undergo phagocytosis have remained unclear. To elucidate the fate of spores internalized by macrophages, we have used time-lapse confocal microscopy to follow individual fluorescent spores over time. By use of this method, we have determined that some phagocytized spores survive beyond germination, to become bacilli that then replicate within the macrophages.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15031802     DOI: 10.1086/382656

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  44 in total

1.  Surface-layer (S-layer) proteins sap and EA1 govern the binding of the S-layer-associated protein BslO at the cell septa of Bacillus anthracis.

Authors:  Valerie J Kern; Justin W Kern; Julie A Theriot; Olaf Schneewind; Dominique Missiakas
Journal:  J Bacteriol       Date:  2012-05-18       Impact factor: 3.490

2.  A dynamic dose-response model to account for exposure patterns in risk assessment: a case study in inhalation anthrax.

Authors:  Bryan T Mayer; James S Koopman; Edward L Ionides; Josep M Pujol; Joseph N S Eisenberg
Journal:  J R Soc Interface       Date:  2010-11-10       Impact factor: 4.118

3.  Tracking bacterial infection of macrophages using a novel red-emission pH sensor.

Authors:  Yuguang Jin; Yanqing Tian; Weiwen Zhang; Sei-Hum Jang; Alex K-Y Jen; Deirdre R Meldrum
Journal:  Anal Bioanal Chem       Date:  2010-08-19       Impact factor: 4.142

4.  The superoxide dismutases of Bacillus anthracis do not cooperatively protect against endogenous superoxide stress.

Authors:  Karla D Passalacqua; Nicholas H Bergman; Amy Herring-Palmer; Philip Hanna
Journal:  J Bacteriol       Date:  2006-06       Impact factor: 3.490

5.  Antimicrobial effects of interferon-inducible CXC chemokines against Bacillus anthracis spores and bacilli.

Authors:  Matthew A Crawford; Yinghua Zhu; Candace S Green; Marie D Burdick; Patrick Sanz; Farhang Alem; Alison D O'Brien; Borna Mehrad; Robert M Strieter; Molly A Hughes
Journal:  Infect Immun       Date:  2009-01-29       Impact factor: 3.441

6.  Poly-gamma-glutamate capsule-degrading enzyme treatment enhances phagocytosis and killing of encapsulated Bacillus anthracis.

Authors:  Angelo Scorpio; Donald J Chabot; William A Day; David K O'brien; Nicholas J Vietri; Yoshifumi Itoh; Mansour Mohamadzadeh; Arthur M Friedlander
Journal:  Antimicrob Agents Chemother       Date:  2006-10-30       Impact factor: 5.191

7.  Four superoxide dismutases contribute to Bacillus anthracis virulence and provide spores with redundant protection from oxidative stress.

Authors:  Robert J Cybulski; Patrick Sanz; Farhang Alem; Scott Stibitz; Robert L Bull; Alison D O'Brien
Journal:  Infect Immun       Date:  2008-10-27       Impact factor: 3.441

8.  Transcriptional profiling of Bacillus anthracis during infection of host macrophages.

Authors:  Nicholas H Bergman; Erica C Anderson; Ellen E Swenson; Brian K Janes; Nathan Fisher; Matthew M Niemeyer; Amy D Miyoshi; Philip C Hanna
Journal:  Infect Immun       Date:  2007-04-30       Impact factor: 3.441

9.  BslA, the S-layer adhesin of B. anthracis, is a virulence factor for anthrax pathogenesis.

Authors:  Justin Kern; Olaf Schneewind
Journal:  Mol Microbiol       Date:  2009-11-10       Impact factor: 3.501

10.  Bacillus anthracis acetyltransferases PatA1 and PatA2 modify the secondary cell wall polysaccharide and affect the assembly of S-layer proteins.

Authors:  J Mark Lunderberg; Sao-Mai Nguyen-Mau; G Stefan Richter; Ya-Ting Wang; Jonathan Dworkin; Dominique M Missiakas; Olaf Schneewind
Journal:  J Bacteriol       Date:  2012-12-14       Impact factor: 3.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.